OSU technologies funded for development( Stillwater Okla.OSUs Technology Busi...)

Stillwater, Okla.OSUs Technology Business Assessment Group will fund four faculty research projects for spring 2008. The group identified these one-year projects from a number of excellent proposals submitted in response to a solicitation earlier this spring. Funding for the program is administered by the OSU Office of Intellectual Property Management, and is generated by royalties from OSU-licensed technologies. These funded projects show a significant probability of having commercial success.

We are pleased that the OIPM royalty stream allowed us to hold yet another competition for the spring of 2008, Steve Price, director of OIPM, said. Its exciting to be able to continue the trend of developing OSU research into viable commercial products.

Created in 2005, TBAG funds projects in need of feasibility demonstration and/or prototype development for commercialization purposes. The group is comprised of private sector partners experienced in new product identification and new technology evaluation, representation from i2E, early-stage capital investors, bankers, representation from Meridian Technology Center for Business Development, the OSU Center for Innovation and Economic Development, the OSU Vice President for Research and Technology Transfer, the OSU Associate Vice President for Technology Development and OSU-Okmulgee.

The OSU research projects selected to receive more than $102,000 from TBAG this year include:

• Heather Gappa-Fahlenkamp, Development of a 3D Human Tissue Model for Screening Potential Diabetic Macular Edema Therapeutics, School of Chemical Engineering. With a current 3D human tissue model made up of endothelial cells, the cells that line blood vessels, and collagen, the most abundant protein in tissue, Fahlenkamp has been able to mimic the interface between a blood vessel wall and the surrounding tissue to study the migration and differentiation of immune cells associated with diabetes. B
  '/>"/>